ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 93 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2021. The put-call ratio across all filers is 3.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $8,624,000 | -54.3% | 2,024,400 | -43.0% | 0.15% | -54.0% |
| Q1 2021 | $18,851,000 | -1.5% | 3,550,000 | 0.0% | 0.33% | -1.2% |
| Q4 2020 | $19,135,000 | -78.2% | 3,550,000 | -67.7% | 0.33% | -73.5% |
| Q3 2020 | $87,780,000 | -12.4% | 11,000,000 | +7.8% | 1.25% | -37.0% |
| Q2 2020 | $100,170,000 | +2871.5% | 10,200,000 | +5446.5% | 1.98% | +113.4% |
| Q2 2015 | $3,371,000 | – | 183,900 | – | 0.93% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 15,832,611 | $68,080,000 | 3.54% |
| Matrix Capital Management Company, LP | 28,000,000 | $120,400,000 | 3.21% |
| Virtus ETF Advisers LLC | 50,655 | $218,000 | 0.46% |
| TFG Asset Management GP Ltd | 500,000 | $2,150,000 | 0.27% |
| Rock Springs Capital Management LP | 800,000 | $3,440,000 | 0.13% |
| Orbimed Advisors | 1,350,655 | $5,808,000 | 0.09% |
| Vident Investment Advisory, LLC | 289,340 | $1,244,000 | 0.07% |
| WS MANAGEMENT LLLP | 185,537 | $798,000 | 0.05% |
| Rathbones Group PLC | 285,722 | $1,229,000 | 0.04% |
| Tekla Capital Management LLC | 228,496 | $983,000 | 0.04% |